REPRESENTATION OF DIFFERENT LYMPHOCYTES' POPULATIONS IN PERIPHERAL BLOOD OF PATIENTS WITH UTERINE MYOMA

par Ye. E. Zueva, N. V. Kulagina, L. S. Komarova, A. V. Kurtova, I. V. Molchanova, E. F. Alekseeva, Areg A. Totolian
Publié 2014

CLINICAL EFFICACY OF GESTAGENS IN PATIENTS WITH UTERINE MYOMA AND HYPERPOLYMENORRHEA

par I. I. Kovalenko, L. V. Suturina
Publié 2012

Lipid peroxidation and antioxidant status in blood of patients with uterine myoma, endometrial polypus, hyperplastic and malignant endometrium

par PEJIC,SNEZANA, KASAPOVIC,JELENA, TODOROVIC,ANA, STOJILJKOVIC,VESNA, PAJOVIC,SNEZANA B
Publié 2006

IMMUNE PARAMETERS OF THE PERITONEAL FLUID IN UTERINE MYOMA. PROGNOSTIC RELEVANCE

par A. I. Malyshkina, N. Ju. Sotnikova, L. V. Posiseeva, Ju. S. Antzyferova
Publié 2014

Blood bisphenol A concentration in patient with infertility affects in vitro fertilization outcomes

par Anastasia G. Syrkasheva, Svetlana V. Kindysheva, Nataliya L. Starodubtseva, Vladimir E. Frankevich, Nataliya V. Dolgushina
Publié 2021

Surgical Treatment of “Large Uterine Masses” in Pregnancy: A Single-Center Experience

par Anna Franca Cavaliere, Annalisa Vidiri, Salvatore Gueli Alletti, Anna Fagotti, Maria Concetta La Milia, Silvia Perossini, Stefano Restaino, Giuseppe Vizzielli, Antonio Lanzone, Giovanni Scambia
Publié 2021

SERUM LEVELS OF HEMOPOIETIC AND ANGIOGENESIS GROWTH FACTORS (IL-5, IL-7, IL-9, FGF-β, G-CSF, VEGF AND PDGF) IN WOMEN WITH UTERINE MYOMA

par V. I. Konenkov, E. G. Koroleva, N. B. Orlov, V. F. Prokofiev, A. V. Shevchenko, A. M. Novikov
Publié 2018